United States · Investor

Baxter Ventures

Last cheque observed Oct 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietCorporate VC

SeedSeries ASeries BDigital EntertainmentOil And GasSoftware

Cheques on record
0%of best year0cheques in 12 months, 19 on record
Since the last cheque3282days00hrs00min00sec
Median round$33MRounds led0 of 19Sole investor6 roundsExits2 from the portfolioMostly inUnited States, 63%
Pitch Baxter Ventures

Baxter Ventures highlights

  1. 01

    19 rounds on record

  2. 02

    Mostly Series C and Series B: 63% of its rounds

  3. 03

    Sole investor in 6 rounds, median $6.5M

  4. 04

    2 exits from the portfolio

What they do

Type
Corporate VC (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowth
Sectors
Digital EntertainmentOil And GasSoftware
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first19 appearances

  1. 2017

    2 rounds

  2. Oct
    VitalConnectSeries C · US · FinSMEs$38MWith 1 other
  3. May
    VitalConnectSeries C · US · FinSMEs$33MWith 1 other
  4. 2016

    1 round

  5. Jun
    Kit CheckSeries C · US · Kitcheck$15MSole investor
  6. 2015

    5 rounds

  7. Oct
    Opsonix, Inc.Series A · US$8.0MSole investor
  8. Oct
    TVA MedicalSeries C · US$15MWith 4 others
  9. Sept
    SANIFITSeries C · ES$41MWith 6 others
  10. May
    Precision BioSciencesSeries A · US$26MWith 5 others
  11. Apr
    True North TherapeuticsSeries B · US$35MWith 4 others
  12. 2014

    2 rounds

  13. Feb
    CovagenSeries B · CH$2.8MSole investor
  14. Jan
    Xenetic BiosciencesVenture · GB$10MSole investor
  15. 2013

    5 rounds

  16. Dec
    CovagenSeries B · CH · pehub.com$47MWith 7 others
  17. Oct
    OpsonaSeries C · IE · finsmes.com$3.9MWith 8 others
  18. Jun
    Ocular TherapeutixSeries E · US · bizjournals.com$8.5MWith 1 other
  19. Apr
    OpsonaSeries C · IE · finsmes.com$43MWith 7 others
  20. Jan
    ZytoprotecSeries A · AT · fiercebiotech.com$2.7MSole investor
  21. 2012

    4 rounds

  22. Dec
    Regado BiosciencesSeries E · US · regadobio.investorroom.com$51MWith 8 others
  23. Dec
    NaurexSeries B · US · fiercebiotech.com$38MWith 6 others
  24. Nov
    Mirna TherapeuticsSeries D · US · sec.gov$17MWith 10 others
  25. Oct
    GliknikSeries B · US · finsmes.com$4.9MSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 8 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

NaurexBought by Allergan$560MJul 2015
CovagenBought by CilagUndisclosedAug 2014

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Baxter Ventures. A count of rooms they were both in, not a relationship either has claimed.

Novartis Venture FundCorporate VC3rounds togetherAmgenCorporate VC2rounds togetherBB Biotech VenturesGrowth equity2rounds togetherEMBL VenturesVC firm2rounds togetherEdmond de Rothschild Venture CapitalGrowth equity2rounds togetherFountain Healthcare PartnersVC firm2rounds togetherOsage University PartnersVC firm2rounds togetherRoche Venture FundCorporate VC2rounds togetherSante VenturesVC firm2rounds togetherSunstone Life Science VenturesVC firm2rounds together

Recently backed

The latest companies Baxter Ventures put money into.

VitalConnect$38M · Oct 2017

Quick answers about Baxter Ventures

What does Baxter Ventures invest in?

Baxter Ventures invests most often at Series C and Series B (63% of the rounds on record), in sectors such as Digital Entertainment, Oil And Gas and Software.

How active is Baxter Ventures?

19 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2017.

What has Baxter Ventures invested in recently?

Its most recent investments on record: VitalConnect (Series C, Oct 2017) and Kit Check (Series C, Jun 2016).

How big are Baxter Ventures's cheques?

The median round it joins is $33M.

Does Baxter Ventures lead rounds?

Rarely, if at all: none of its 19 investments on record names it as the lead.

Where does Baxter Ventures invest?

Most of the companies it backs are in the United States (63%), Switzerland (11%) and Ireland (11%).

Is Baxter Ventures investing now?

No investments in the last 12 months; the latest was in Oct 2017.

Who does Baxter Ventures invest alongside?

Most often Novartis Venture Fund (3 rounds together), Amgen (2 rounds together) and BB Biotech Ventures (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it